HHS Public Access Author manuscript Author Manuscript

J Int Assoc Provid AIDS Care. Author manuscript; available in PMC 2017 November 01. Published in final edited form as: J Int Assoc Provid AIDS Care. 2016 November ; 15(6): 455–458. doi:10.1177/2325957416667486.

Prescription of Pneumocystis jiroveci pneumonia prophylaxis in HIV-infected patients Xia Lin, PhD1,2, Shikha Garg, MD2, Christine L. Mattson, PhD2, Qingwei Luo, MS3, and Jacek Skarbinski, MD2 For the Medical Monitoring Project 1Epidemic

Intelligence Service, Centers for Disease Control and Prevention (CDC), Atlanta, GA,

USA

Author Manuscript

2Division

of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, CDC, Atlanta, GA, USA 3ICF

International, Atlanta, GA, USA

Abstract

Author Manuscript

U.S. treatment guidelines recommend Pneumocystis jiroveci pneumonia (PCP) prophylaxis for all HIV-infected persons with CD4+ T-lymphocyte (CD4) counts